Drugs / Plasma Rich in Growth Factor (PRGF) Supplementation
Plasma Rich in Growth Factor (PRGF) Supplementation
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04731233 | Mar 2021 → Feb 2024 | osteoarthritis, temporomandibular joint disorder | University of Florida | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasma Rich in Growth Factor (PRGF) Supplementation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04731233 ↗ |
| Action | Restore | “Plasma rich in growth factors is isolated from the patient's own blood and injected into the temporomandibular joint to activate stem cells that may restore some of the...” NCT04731233 ↗ |
| Modality | Protein / enzyme biologic | “PRGF supplementation which is an autologous platelet-enriched plasma obtained from patient's own blood, which after activation with calcium chloride allows the release of a...” NCT04731233 ↗ |
| Route | Other | “injected into the temporomandibular joint” NCT04731233 ↗ |